Project Grant R01NS142389

Award Date 6/15/25
Completion Date 4/30/30
Dollars Obligated $614K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45229, USA
Similar Awards
This $1,550,682 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to understand the mechanisms controlling central nervous system (CNS) myelin sheath length and their implications for neurological disorders. The primary objective is to determine how axon diameter serves as an instructive cue that triggers oligodendrocyte...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $444,599 to investigate the impact of neuronal activity on oligodendrocyte progenitor cell differentiation and myelination. The research aims to characterize transcriptome changes in oligodendrocyte progenitor cells when cortical neuronal activity is manipulated using designer...
The National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded The Ohio State University a $119,018 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders program. This grant will support research into strategies to interrogate and enhance myelin remodeling in distal tissue after spinal cord injury. The goal of the NINDS program is to fund basic and applied research exploring the brain, nervous system structure...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will support research at Kenyon College to characterize the cellular and molecular mechanisms of Schwann cell demyelination and identify factors that promote peripheral nerve remyelination. The $454,424 award, effective April 1, 2025 through March 31, 2028, will enable the...
This Project Grant award, valued at $352,073.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award supports research focused on developing a therapeutic to address demyelinating neuropathies, a class of neurological disorders characterized by impaired myelin formation. Specifically, the research will investigate the use of an...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $233,250.00 to The Washington University to investigate the potential of hyperpolarized 13C magnetic resonance spectroscopic imaging (HP 13C MRSI) and ultra-short echo time magnetization transfer (UTE-MT) imaging to non-invasively study the role of lactate metabolism and...
This $440,275 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will support research to systematically discover upstream regulators of the OLIG2 transcription factor, which plays a central role in the myelination of the central nervous system (CNS) by oligodendrocytes. The 2-year project aims to determine the in vivo role of the MEF2D...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $599,204 to The Leland Stanford Junior University to investigate the cellular mechanisms driving learning-induced myelin remodeling and its role in motor learning. The key objectives are to determine if oligodendrocyte calcium signaling is required for myelin sheath...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $147,656.00 to Duke University for research investigating human-specific splicing regulation in neurogenesis and disease. The research aims to define a novel mechanism of action for human-specific non-coding genome regions in regulating post-transcriptional RNA processing...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $667,644 to the Icahn School of Medicine at Mount Sinai to conduct research on cortical demyelination and repair in early multiple sclerosis (MS). The key objectives of this 5-year project are to: 1) determine how cortical and white matter demyelination are related in...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $614,009 to support research focused on understanding the molecular mechanisms involved in oligodendrocyte myelination and remyelination. The goal is to identify critical factors that promote myelin production and overcome inhibitory signals, with the aim of improving myelin repair in demyelinating diseases like multiple sclerosis. Key research activities include utilizing spatio-temporally specific mutagenesis approaches to study the role of class I histone deacetylase isoforms in remyelination, as well as investigating the regulatory network involving the HDAC3-ZNHIT1 complex and its impact on myelination and remyelination. The award period runs from June 15, 2025 to April 30, 2030, and the research will be conducted at the Children's Hospital Medical Center in Cincinnati, Ohio.

Generated 6/24/25, 3:03 AM